Found: 35
Select item for more details and to access through your institution.
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1035370
- By:
- Publication type:
- Article
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1046, doi. 10.3390/cancers12041046
- By:
- Publication type:
- Article
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 954, doi. 10.3390/cancers12040954
- By:
- Publication type:
- Article
Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase‐Positive Non‐Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 487, doi. 10.1111/cts.12921
- By:
- Publication type:
- Article
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Apurinic/apyrimidinic endonuclease 1, p53, and thioredoxin are linked in control of aging in C. elegans.
- Published in:
- Aging Cell, 2010, v. 9, n. 3, p. 420, doi. 10.1111/j.1474-9726.2010.00572.x
- By:
- Publication type:
- Article
Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans.
- Published in:
- Aging Cell, 2008, v. 7, n. 2, p. 260, doi. 10.1111/j.1474-9726.2008.00371.x
- By:
- Publication type:
- Article
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921996509
- By:
- Publication type:
- Article
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921996509
- By:
- Publication type:
- Article
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 524, doi. 10.1038/s41416-024-02746-z
- By:
- Publication type:
- Article
Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Deficient CD247 expression is a typical histopathological characteristic of thymomas with cortical features.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
C. elegans as Model for the Study of High Glucose-Mediated Life Span Reduction.
- Published in:
- Diabetes, 2009, v. 58, n. 11, p. 2450, doi. 10.2337/db09-0567
- By:
- Publication type:
- Article
Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 134, n. 1, p. 205, doi. 10.1007/s11060-017-2510-0
- By:
- Publication type:
- Article
Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.673901
- By:
- Publication type:
- Article
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.703893
- By:
- Publication type:
- Article
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.670483
- By:
- Publication type:
- Article
De Novo Versus Secondary Metastatic EGFR -Mutated Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.640048
- By:
- Publication type:
- Article
Delta-radiomics features of ADC maps as early predictors of treatment response in lung cancer.
- Published in:
- Insights into Imaging, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s13244-024-01787-5
- By:
- Publication type:
- Article
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 6563, doi. 10.2147/CMAR.S180990
- By:
- Publication type:
- Article
No Evidence of Clonal Dominance in Primates up to 4 Years Following Transplantation of Multidrug Resistance 1 Retrovirally Transduced Long-Term Repopulating Cells.
- Published in:
- Stem Cells, 2007, v. 25, n. 10, p. 2610, doi. 10.1634/stemcells.2007-0017
- By:
- Publication type:
- Article
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real‐world data for precision cancer medicine—A European perspective.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 9, p. 557, doi. 10.1002/gcc.23135
- By:
- Publication type:
- Article
Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 3, p. 214, doi. 10.1002/gcc.22427
- By:
- Publication type:
- Article
Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.586449
- By:
- Publication type:
- Article
Re-irradiation in locally recurrent lung cancer patients.
- Published in:
- Strahlentherapie und Onkologie, 2019, v. 195, n. 8, p. 725, doi. 10.1007/s00066-019-01457-2
- By:
- Publication type:
- Article
Rebestrahlung bei Lokalrezidiven von Lungenkarzinomen.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome und Prognosefaktoren bei singulären Hirnmetastasen des kleinzelligen Bronchialkarzinoms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
<italic>EML4‐ALK</italic> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK<sup>+</sup> non‐small cell lung cancer.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 12, p. 2589, doi. 10.1002/ijc.31275
- By:
- Publication type:
- Article